News Focus
News Focus
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: F1ash post# 127407

Monday, 10/30/2017 4:02:03 PM

Monday, October 30, 2017 4:02:03 PM

Post# of 518942
And when Dr Perry says:

“I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug.”

Is he referring to just MMSE scores? He’s referring other cognitive tests as well isn’t he?

Do you disagree with the nation’s leading Alzheimer’s researcher? That’s fine if you do.

Again, I’m just listening to the experts and various CNS disease indications’ presentations and reading the slides & abstracts that are put in front of me.

By all means, anyone that is risk adverse should wait for FDA approval, if it comes. I am not a scientist.

Good luck

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News